Circulating PUFAs and their associations with abdominal obesity and hyperglycaemia among vegetarians and non-vegetarians: Insights for personalised nutrition from a cross-sectional study

Read full text
Authors: Yuan Kei Ching, Yit Siew Chin, Mahenderan Appukutty, Yoke Mun Chan
Cited by: 0
References: 25

Abstract

This study explores the associations between circulating polyunsaturated fatty acids (PUFAs), abdominal obesity and hyperglycaemia among vegetarians and non-vegetarians with distinct dietary PUFA intakes, as limited evidence exists on how circulating PUFA concentrations differ between these dietary groups and relate to metabolic risks. In this cross-sectional study, serum PUFA profiles and their associations with abdominal obesity and hyperglycaemia were examined. A total of 127 vegetarians and 132 non-vegetarians from Malaysia participated in the present study. Vegetarians had higher circulating concentrations of linoleic acid (LA), alpha-linolenic acid (ALA), and the n-6:n-3 PUFA ratio. They had lower concentrations of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) than non-vegetarians. Among vegetarians, higher circulating arachidonic acid (ARA) concentrations were associated with an increased risk of hyperglycaemia (odds ratio [OR]: 1.06, 95% confidence interval [CI]: 1.00-1.11). In non-vegetarians, higher circulating ARA was associated with a higher risk of abdominal obesity (OR: 1.05, 95% CI: 1.00-1.09), while lower circulating DHA was associated with a reduced odds of abdominal obesity (OR: 0.95, 95% CI: 0.90-0.99). Conversely, a high circulating n-6:n-3 PUFA ratio was associated with a lower risk of hyperglycaemia (OR: 0.96, 95% CI: 0.93 - 1.00) among non-vegetarians. These findings highlight distinct metabolic responses to PUFA profiles between vegetarians and non-vegetarians, suggesting the need for tailored dietary strategies to address abdominal obesity and hyperglycaemia for both groups.

Fields of Study & Subjects

Fatty Acid Research and Health Peroxisome Proliferator-Activated Receptors Eicosanoids and Hypertension Pharmacology

Publication details

Journal / source
PLoS ONE
Volume
21
Issue
1
Pages
e0337509–e0337509
Publication date
7 January 2026
Language
EN